Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Ovarian Epithelial × 3-aminopyridine-2-carboxaldehyde thiosemicarbazone × Clear all

Sponsor

Conditions

Uterine Cervical Neoplasms 3 Vaginal Neoplasms 2 Thrombocythemia, Essential 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Neuroendocrine Tumors 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Accelerated Phase 1 Gallbladder Neoplasms 1 Blast Crisis 1

Interventions

Paclitaxel 21 Carboplatin 16 liposomal doxorubicin 12 Bevacizumab 8 Topotecan 7 Docetaxel 7 Cisplatin 7 pembrolizumab 6 rucaparib 5 mirvetuximab soravtansine 5 Gemcitabine 5 Cyclophosphamide 5 Taxes 4 Albumin-Bound Paclitaxel 4 sargramostim 3 ixabepilone 3 Cytoreduction Surgical Procedures 3 130-nm albumin-bound paclitaxel 3 taxane 2 talazoparib 2 pazopanib 2 fludarabine phosphate 2 fludarabine 2 denileukin diftitox 2 cediranib 2 catumaxomab 2 belinostat 2 avelumab 2 aflibercept 2 Surgical Procedures, Operative 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡